Divisions & subsidiaries
A dedicated team exploring promising opportunities for innovative therapies
Forest Pharmaceuticals
Forest Pharmaceuticals, Inc., the St. Louis-based subsidiary of Forest Laboratories,
Inc. is responsible for the manufacture, sale, and distribution of Forest-branded
ethical prescription products in the United States. Our 2,800-member, professionally-trained
sales force markets our products directly to healthcare providers, hospitals, managed
care organizations, and pharmacies. Forest Pharmaceuticals employs state-of-the-art
production centers, innovative customer service strategies, and a collaborative work
environment to anticipate and meet the evolving needs of our customers. www.forestpharm.com
Back to Top
Forest Laboratories Europe
Forest Laboratories Europe is the wholly-owned European subsidiary of Forest Laboratories,
Inc. We sell prescription branded ethical products and non-prescription drugs sold
over-the-counter to treat a range of illnesses. Our two manufacturing sites in Dublin
and third in Bexley, Kent, make products for the domestic and export markets including:
the UK, Ireland, Holland, Greece, Poland, Hungary, and other markets in the Middle
East and Australasia. In the UK and Ireland, we market our products through our
sales force. In other countries, Forest works in partnership with pharmaceutical
marketers to distribute products. www.forestlabs.com
Back to Top
Forest Research Institute, Inc.
Forest Research Institute, Inc., a wholly-owned subsidiary of Forest Laboratories,
Inc., drives the research, development, and clinical evaluation of our pharmaceutical
products and provides ongoing scientific support for our commercialized products.
The Institute operates research centers in Jersey City, New Jersey, and on Long Island,
New York, and staffs clinical trial personnel across the country to coordinate studies.
Increased productivity in R&D at Forest in recent years has driven the expansion
of key areas such as: Project Management and Development, Pharmacology, Toxicology,
Clinical Pharmacology and Biometrics, Clinical Development and Medical Affairs,
and Pharmaceutical R&D. www.frx.com/research
Back to Top
Cerexa, Inc.
Cerexa, a wholly-owned subsidiary of Forest Laboratories, Inc., is an innovation
driven, biopharmaceutical company focused on discovering, developing, and commercializing
a growing portfolio of novel anti-infective therapies for the treatment of serious
and life-threatening infections. Cerexa’s lead product candidate, ceftaroline acetate,
is a next-generation, broad-spectrum, injectable cephalosporin with anti-MSRA activity.
Based in Alameda, CA, Cerexa initiated operations in July 2005 and was acquired
by Forest in January 2007. www.cerexa.com
Back to Top
Inwood Laboratories
Inwood Laboratories is the Commack, New York-based subsidiary of Forest Laboratories,
Inc. that makes and supplies mostly generic equivalents of Forest’s branded pharmaceutical
products. Our generic products are used to treat illnesses including depression,
hypertension, asthma, and angina. They meet the highest quality and safety standards
set by the Forest brands they replicate, and are approved by the US Food and Drug
Administration under the same New Drug Application as their brand counterparts.
www.inwoodlabs.com
Back to Top